Adial Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -553.7% | -553.7% | -259.8% |
| FY2022 | -388.6% | -388.6% | -222.1% |
| FY2023 | -125.5% | -125.5% | -108.2% |
| FY2024 | -324.4% | -324.4% | -261.6% |
| FY2025 | -151.2% | -151.2% | -119.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -553.7% | -553.7% | -259.8% |
| FY2022 | -388.6% | -388.6% | -222.1% |
| FY2023 | -125.5% | -125.5% | -108.2% |
| FY2024 | -324.4% | -324.4% | -261.6% |
| FY2025 | -151.2% | -151.2% | -119.5% |